RxDoctor Payments Data

Dana Demmitt

Family · Franklin, OHNPI 1710442710

Payments from drug & device makers

$4,466in general payments, 2019–2025

Across 426 payments — averaging $10.48 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$2K
  • Johnson & Johnson$532
  • Novo Nordisk$505
  • Corium, LLC$215
  • AstraZeneca$210
  • Nestle Healthcare Nutrition Inc.$193
  • plus $670 from 17 others

What the payments were for

  • Food & beverage$4,466100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$4,466 in reported general payments places this provider in the 90th percentile of 6,812 family providers in Ohio.

See all family providers in Ohio

Medicare billing

Part B allowed, 2024
$12,125
Medicare patients
36
Services billed
180

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide26$37,014
Trelegy ElliptaFluticasone/Umeclidin/Vilanter14$9,086
Buprenorphine-NaloxoneBuprenorphine Hcl/Naloxone Hcl37$5,841
SuboxoneBuprenorphine Hcl/Naloxone Hcl17$4,366
Duloxetine Hcl54$1,251
SynthroidLevothyroxine Sodium26$1,096
Albuterol Sulfate HfaAlbuterol Sulfate54$1,067
Gabapentin63$852
Ezetimibe20$823
Atorvastatin Calcium137$727
Levothyroxine Sodium92$666
Liothyronine Sodium16$581
Pregabalin11$532
Pravastatin Sodium20$347
Omeprazole61$307

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic$505$37,01426 claims
AbbVieSynthroid$2,141$1,09626 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 6,812 family providers in Ohio.

Other family in Franklin

See the full list for Ohio

Where these figures come from

Is this you, or does something look wrong? →